Szívelégtelenség: vizsgálatok itt: Kína
145 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- No phaseTaking peopleSOCIAL_HF: Improving Social Frailty Through Interactive Learning
- Where
- Shanghai
- Életkor
- 60 év and over
- People
- 208
- Run by
- The University of Hong Kong
See details and how to joinNCT07234565 - 3. fázisTaking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Baotou, Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Guangzhou, Hangzhou, Harbin, Hengyang, Heze, Hohhot, Jinan, Jining, Lanzhou, Liaocheng, Linhai, Nanchang, Nanchong, Nanjing, Ningbo, Pingxiang, Quzhou, Sanya, Shanghai, Shenyang, Shenzhen, Ürümqi, Wuhan, Xi'an, Xianyang, Xuzhou, Yangzhou, Zhangjiakou, Zunyi
- Életkor
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleA Village Doctor-led Telehealth Supported Trial of Heart Failure Prevention in AF Patients: MIRACLE-AF 2 (Heart Failure Prevention)
- Where
- Xuzhou, Yancheng, Yangzhou
- Életkor
- 65 év to 80 év
- People
- 1356
- Run by
- Jiangsu Taizhou People's Hospital
See details and how to joinNCT07492498 - No phaseTaking peopleA Village Doctor-led Telehealth Supported Improvement of Outcomes of AF Patients With Heart Failure Due to Reduced or Preserved Ejection Fraction: The MIRACLE-AF 2 Heart Failure Management Trial (MIRACLE AF-HF)
- Where
- Xuzhou, Yancheng, Yangzhou
- Életkor
- 65 év to 80 év
- People
- 942
- Run by
- Jiangsu Taizhou People's Hospital
See details and how to joinNCT07492524 - 3. fázisTaking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Baoding, Baotou, Beijing, Bozhou, Changchun, Changde, Changsha, Chengdu, Chifeng, Daqing, Foshan, Guangzhou, Haikou, Hefei, Heze, Huaian, Huizhou, Jiangmen, Jinan, Jining, Lanzhou, Linhai, Lishui, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Panjin, Pingxiang, Qingzhou, Sanya, Shanghai, Shantou, Shaoguan, Shaoxing, Shenyang, Shenzhen, Siping, Suining, Suzhou, Taian, Tianjin, Ürümqi, Wanzhou, Weifang, Wenzhou, Wuhan, Wuxi, Xi'an, Xiangtan, Xuzhou, Yancheng, Yangzhou, Yueyang, Yuncheng, Zhangjiakou, Zhengzhou, Zibo, Zigong, Zunyi
- Életkor
- 18 év and over
- People
- 6950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - No phaseNot yet taking people in KínaReal-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure
- Where
- Jinan, Tianjin
- Életkor
- 40 év to 80 év
- People
- 200
- Run by
- China Academy of Chinese Medical Sciences
See details and how to joinNCT07841275 - 2. fázisTaking peoplePhase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 153
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07318103 - No phaseNot yet taking people in KínaReal-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 5000
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07044700 - 2/3. fázisTaking peopleAtrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 208
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07820410 - No phaseTaking peopleSafety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 400
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07414225 - No phaseTaking peopleClinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure
- Where
- Nanchang
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07814612 - 3. fázisTaking peopleA Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- Where
- Changsha, Chengdu, Guangzhou, Hangzhou, Jinan, Shanghai, Taiyuan, Tianjin, Xian City
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06024746 - No phaseNot yet taking people in KínaYiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
- Where
- Guangzhou, Jinan, Tianjin, Zhengzhou
- Életkor
- 40 év to 80 év
- People
- 100
- Run by
- China Academy of Chinese Medical Sciences
See details and how to joinNCT07803471 - 1/2. fázisTaking peopleA Study of Metformin to Improve Cardiac Function After LVAD Implantation
- Where
- Ha’erbin, Hangzhou, Huai'an, Nanjing, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 108
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07666698 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Baotou, Changchun, Changsha, Changzhou, Guangzhou, Harbin, Jinan, Jining, Nanjing, Shanghai, Shenyang, Shijiazhuang, Siping, Suzhou, Tianjin, Wuhan, Xi'an, Xuzhou
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseNot yet taking people in KínaA Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart Failure
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 64
- Run by
- Shenzhen Core Medical Technology CO.,LTD.
See details and how to joinNCT07757451 - No phaseTaking peopleGut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 100
- Run by
- The Second Hospital of Nanjing Medical University
See details and how to joinNCT07621367 - No phaseNot yet taking people in KínaMedical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
- Where
- Taizhou
- Életkor
- 18 év to 65 év
- People
- 20
- Run by
- Jiangsu Taizhou People's Hospital
See details and how to joinNCT07740044 - 3. fázisTaking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Beijing
- Életkor
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - No phaseTaking peopleAI-Optimized Single-Feature Recognition Model for Heart Failure
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 50
- Run by
- Vivalink
See details and how to joinNCT07667452 - No phaseTaking peopleSafety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure
- Where
- Beijing, Hefei
- Életkor
- 18 év and over
- People
- 6
- Run by
- Shenzhen Core Medical Technology CO.,LTD.
See details and how to joinNCT07704424 - 1/2. fázisTaking peopleSafety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 43
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06902896 - No phaseTaking peopleBiomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)
- Where
- Shanghai
- Életkor
- 18 év to 90 év
- People
- 1740
- Run by
- Ruijin Hospital Luwan Branch
See details and how to joinNCT07701876 - 1/2. fázisNot yet taking people in KínaRandomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
- Where
- Xi’an
- Életkor
- 60 év and over
- People
- 162
- Run by
- The First Affiliated Hospital of Air Force Medical University
See details and how to joinNCT07687212 - 1. fázisTaking peopleSafety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 5
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07516288